Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 93-102

  Galbraith, S M ^a   Chaplin, D J ^a   Lee, F ^a   Stratford, M R L ^a   Locke, R J ^a   Vojnovic, B ^a   Tozer, G M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cell shape change; HUVECs; P22 rat carcinosarcoma; Red cell velocity; Tubulin binding agents

Indexed keywords

COLCHICINE; COMBRETASTATIN A4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE SHAPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL SIZE; CELLS, CULTURED; COLCHICINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; KINETICS; MALE; MICROTUBULES; NEOPLASMS, EXPERIMENTAL; RATS; REGIONAL BLOOD FLOW; STILBENES;

EID: 0035064594     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Isolation and structure of combretastatin
2. Interactions of combretascatin, a new plant-derived anti-mitotic atent, wim tubulin
3. Isolation and structure of the strong growth and tubulin inhibitor combretastatin A-4
4. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs
5. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumour vasculature
6. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues
7. Induction of apoptosis in proliferating human endothelial cells by the tumor-specific antiangiogenesis agent combretastatin A-4
8. Effects of novel and conventional anti-cancer agents on human endothelial permeability: Influence of tumour secreted factors
9. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
10. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
11. Methods for computer assisted analysis of lymphoid cell shape and motility, including Fourier analysis of cell outlines
12. Temporal effects of 5.0 Gy radiation in healing subcutaneous microvasculature of a dorsal flap window chamber
13. A transparent access chamber for the rat dorsal skin fold
14. Modification of turnout blood flow using the hypertensive agent, angiotensin 11
15. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion
16. Spreading of cells on various substrates evaluated by Fourier analysis of shape
17. Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress
18. Regulation of endothelin-1 gene expression by cell shape and the microfilament network in vascular endothelium
19. Changes in surface topography in endothelial monolayers with time at confluence: Influence on subcellular shear stress distribution due to flow
20. Geometric control of cell life and death
21. Role of cell shape in growth control
22. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis
23. The relationship between elevated interstitial fluid pressure and blood flow in tumors: A bioengineering analysis
24. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: Clinical implications
25. Determinants of tumor blood flow: A review
26. Endothelial-cell proliferation in experimental tumours
27. Microtubule-associated proteins-dependent colchicine stability of acetylated cold-labile brain microtubules from the Atlantic cod, Gadus morhua
28. Dynamic instability of microtubules assembled from microtubule-associated protein-free tubulin: Neither variability of growth and shortening rates nor "rescue" requires microtubule-associated proteins
29. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau
30. Role of microtubule-associated proteins in the control of microtubule assembly
31. Post-translational modification of microtubules is a component of synergic alterations of cytoskeleton leading to formation of cytoplasmic processes in fibroblasts
32. Microtubules and microtubule-associated proteins
33. Differential expression of tubulin isotypes during the cell cycle
34. Differential sorting of beta tubulin isotypes into colchicine-stable microtubules during neuronal and muscle differentiation of embryonal carcinoma cells
35. Generation of a stable, posttranslationally modified microtubule array is an early event in myogenic differentiation
36. Destabilization of plasma membrane structure by prevention of actin polymerization. Microtubule-dependent tubulation of the plasma membrane
37. Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix
38. Cochicine in the experimental treatment of cancer
39. Antimitotic natural products combretastatin A-4 and combretastatin A-2: Studies on the mechanism of their inhibition of the binding of colchicine to tubulin
40. Conformational states of tubulin liganded to colchicine, tropolone methyl ether, and podophyllotoxin
41. Pharmacokinetics of colchicine: A review of experimental and clinical data
42. Anti-vascular approaches to solid turnout therapy: Evaluation of combretastatin A4 phosphate